Global Cord Blood Corporation (CORBF) stock: key figures, P/E, revenue and dividend
Health Care · Health Care Services · United States · ISIN US6986591096
Global Cord Blood Corporation financials
| Fiscal year | 2021 | 2022 |
|---|---|---|
| Revenue | 1.16 bn CNY | 1.24 bn CNY |
| Gross profit | 980.69 m CNY | 1.06 bn CNY |
| Operating income | 544.87 m CNY | 608.87 m CNY |
| EBIT | 544.87 m CNY | 608.87 m CNY |
| Net income | 508.25 m CNY | 501.07 m CNY |
| Diluted EPS – continuing operations | 4.18 CNY | 4.12 CNY |
Full history since 2007, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Global Cord Blood Corporation
Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation operates as a subsidiary of Blue Ocean Structure Investment Company Ltd.
More stocks
- Viromed Medical (VMED.DE)
- Sable Offshore Corp. (SOC)
- Wendell Industrial Co. Ltd (6761.TWO)
- Securitag Assembly Group Co Ltd (6417.TWO)
- Kangnam Jevisco Co Ltd (000860.KS)
- Prime Office A/S (PRIMOF.CO)
- LENZ Therapeutics, Inc. (LENZ)
- Medinice S.A (ICE.WA)
- GEVORKYAN as (GEV.PR)
- Pine Cliff Energy Ltd (PNE.TO)
- Tai-Saw Technology Co Ltd (3221.TWO)
- Katahdin Bankshares Corp (KTHN)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.